Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

ONXX Did Not Suffer A Trial Failure

|Includes: ONYX Pharmaceuticals, Inc. (ONXX)

It's outrageous that the more or less popular sites such as Wall Street Cheat Sheet do not excercise more care when choosing a title for their articles -

Title: "Cancer drug Nexavar from Bayer and Onyx fails in a late-stage combo trial"

The reality of the situation, quoted from the Article:

"Nexavar treatment for liver cancer, which is made jointly by Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) and Bayer A.G.(OTCPK:BAYZF), was used in combination with Tarceva, but the pairing failed to improve survival rates compared with Nexavar on its own in a Phase III trial."

Nexavar + Tarceva = Nexavar, how'd Nexavar fail?

Disclosure: I am long ONXX.